Drug Discovery Market

1
Drug Discovery Market Trends, Size, Share,
Demands, Overview, Growth, Revenue and Forecast
to 2030
sales_at_delvens.com www.delvens.com
2
Sternal Closure Systems Market Trends Forecast
Till 2030
Drug Discovery Market, By Drug Type (Small
Molecule Drugs and Biologic Drugs), By Technology
(High Throughput Screening, Pharmacogenomics,
Combinatorial Chemistry, Nanotechnology, and
Other Technologies), By End User (Pharmaceutical
Companies, Contract Research Organizations
(CROs), and region (North America, Europe,
Asia-Pacific, Middle East and Africa and South
America).
Request For Free Sample Report
https//www.delvens.com/get-free-sample/drug-disco
very-market
sales_at_delvens.com
www.delvens.com
3
Market Overview
The drug discovery market is experiencing robust
growth driven by several key factors shaping the
pharmaceutical and biopharmaceutical industries
globally. A primary driver is the increasing
incidence of chronic diseases such as cancer,
diabetes, and cardiovascular disorders, which
necessitates the development of novel and more
effective drugs. This trend is further bolstered
by the shift towards personalized medicine, where
treatments are tailored to individual genetic
profiles, enhancing treatment efficacy and
patient outcomes. Technological advancements,
particularly the integration of AI and machine
learning in drug discovery, are revolutionizing
the field. These technologies enable the analysis
of vast datasets to identify potential drug
candidates more efficiently, speeding up the
discovery process. Additionally, collaborations
between pharmaceutical companies and academic
institutions are fostering innovation and
accelerating the development of new
therapies. Purchase this Report
https//www.delvens.com/checkout/drug-discovery-ma
rket
sales_at_delvens.com
www.delvens.com
4
Key Findings
The Drug Discovery Market is segmented into
Product Drug Type, Technology End-User, and
Region On the basis of Drug Type, the
differentiation between small molecule drugs and
biologic drugs is pivotal for driving growth in
the drug discovery market. On the basis of
Technology, the integration of advanced
technologies such as high throughput screening,
pharmacogenomics, combinatorial chemistry,
nanotechnology, and others is pivotal in driving
the growth of the drug discovery market.
sales_at_delvens.com
www.delvens.com
5
Key Findings
On the basis of type, the end-user segment
comprising pharmaceutical companies, contract
research organizations (CROs), biotechnology
firms, and academic/research institutions
collectively drives growth in the drug discovery
market through distinct contributions. The
market is also divided into various regions such
as North America, Europe, Asia-Pacific, South
America, and Middle East and Africa. North
America is estimated to account for the largest
market share during the forecast period. Inquire
Before Buying https//www.delvens.com/Inquire-bef
ore-buying/drug-discovery-market
sales_at_delvens.com
www.delvens.com
6
Competitive Landscape

• Pfizer Inc.
• Novartis AG
• Merck Co., Inc.
• Johnson Johnson
• Roche Holding AG
• Sanofi
• AstraZeneca plc
• GlaxoSmithKline plc
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• AbbVie Inc.
• Amgen Inc.

• Biogen Inc.
• Gilead Sciences, Inc.
• Regeneron Pharmaceuticals, Inc.
• Vertex Pharmaceuticals Incorporated
• Takeda Pharmaceutical Company Limited
• Bayer AG
• Moderna, Inc.
• BioNTech SE
• Vertex Pharmaceuticals
• Ionis Pharmaceuticals
• Genentech, Inc.
• Alexion Pharmaceuticals

sales_at_delvens.com
www.delvens.com
7
Recent Developments
In October 2022, Verge Genomics, a biotechnology
company at the clinical stage leveraging AI and
human data to revolutionize drug discovery, has
initiated dosing the first participant in its
Phase 1 clinical trial for VRG50635. In August
2022, NGM Bio unveiled the top-line findings from
the CATALINA Phase 2 Trial of NGM621, targeting
patients with geographic atrophy (GA) due to
age-related macular degeneration.
sales_at_delvens.com
www.delvens.com
8
Contact Information
About Us Delvens is a strategic advisory and
consulting company headquartered in New Delhi,
India. The company holds expertise in providing
syndicated research reports, customized research
reports and consulting services. Delvens
qualitative and quantitative data is highly
utilized by each level from niche to major
markets, serving more than 1K prominent companies
by assuring to provide the information on
country, regional and global business
environment. We have a database for more than 45
industries in more than 115 major countries
globally. Contact Us 44-20-3290-6466 1
214-377-1144 sales_at_delvens.com
sales_at_delvens.com
www.delvens.com